Author: BioViva Sciences

We are gene therapy innovation leaders. We develop platforms to treat severe genetic disorders and cellular aging. We are working on several patients and are seeking strategic partnerships to help us in our efforts to bring cures to aging populations and those who suffer from monogenic disease. At the heart of Bioviva’s product creation efforts is it’s broadly applicable gene therapy platform for the development of novel one time treatments for diseases with either ineffective or no clinical options.

Alzheimer’s Gene Therapy Human Study Seeks Volunteers

14 October 2019

Integrated Health Systems, in partnership with Maximum Life Foundation, is funding a trial to rejuvenate microglial cells using telomerase gene therapy. This trial is...

Read more